Pharmaceuticals

Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market (Types, Drugs and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

  • ALL144304
  • 0 Pages
  • November 1999
  • Pharmaceuticals

Acute Lymphocytic/Lymphoblastic leukemia is a kind of blood or bone marrow cancer. It occurs in lymphocytes which are white blood cells. It can then easily spread to the other parts of the body such as liver, spleen, lymph nodes and others. The number of cases of these diseases is rising at an alarming rate all over the globe. The rising incidence of acute Lymphoblastic/ Lymphocytic leukemia and innovative therapies related to it are the major drivers for this market. Moreover, oncology market therapies are witnessing substantial growth due to unmet needs;this is also propelling the market. However, the high cost associated with the treatment of these diseases, unfavorable outcomes related to the treatment and lower capability of drug production are the major restraints of this market. The companies profiled in this report are GlaxoSmithKline Plc, Sigma-TauPharmaceuticals Inc., Erytech Pharma, Genzyme Corporation, Pfizer Inc, Talon Therapeutics, Inc. and (Spectrum Pharmaceuticals, Inc.).



The Acute Lymphocytic/Lymphoblastic leukemia market is segmented into types, drugs and geography. On the basis of types the Acute Lymphocytic/Lymphoblastic leukemia market is segmented into Acute Lymphocytic/Lymphoblastic Leukemia for child and

Acute Lymphocytic/Lymphoblastic Leukemia for adult. Acute Lymphocytic/Lymphoblastic Leukemia for child holds the highest market share due to the rising incidence of these diseases in children as opposed to adults. On the basis of drugs, the market is segmented into pipeline drugs and existing drugs and they are further sub-segmented as well. On the basis of geography the market is segmented into various regions, namely, North America, Europe, Asia Pacific and LAMEA. The North American region holds the highest share in this market due to the rising incidence of Acute Lymphocytic Leukaemia in the United States.



KEY BENEFITS




  • In-depth analyses of the factors that limit and drive the growth of the market are provided

  • Detailed analysis of various geographies would give an understanding of the trends in various regions so that companies can make region specific plans

  • Deep dive analyses of segments such as types and drugs used will provide insights that would enable companies to gain competitive edge

  • Porter’s Five Force and other models would help in productive business decisions

  • On-the-whole market analysis would assist in assessing the growth opportunities in this market



KEY DELIVERABLES



The global Acute Lymphocytic/Lymphoblastic leukemia Marketis segmented according to type, drugs and geography as follows:



MARKET BY TYPE




  • Acute Lymphocytic/Lymphoblastic Leukemia For Child

  • Acute Lymphocytic/Lymphoblastic Leukemia For Adult



MARKET BY DRUGS




  • Pipeline Drugs (Phase III)


    • Graspa

    • Inotuzumab Ozogamicin

    • Marqibo



  • Existing Regimens/Drugs

    • Hyper-CVAD Regimen

    • Linker Regimen

    • Oncaspar

    • Nucleoside Metabolic Inhibitors (Clolar and Nelarabine)

    • CALGB 8811 Regimen





By Geography




  • North America

  • Europe

  • Asia Pacific

  • LAMEA


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Cancer Therapeutics and Biotherapeutic Market (Technology, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

Cancer is one of the leading causes of death worldwide. According to the World Health Organization, about 8.2 million deaths occurred in 2012 due to cancer. The most ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

World Pharmaceutical Excipients Market - Opportunities and Forecasts, 2015 - 2020

Pharmaceuticals excipient is a substance added with an active ingredient during manufacturing process of a drug. It helps in long term stabilization, reduction of viscosity, and enhancement of solubility of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Nephrology and Urology Devices Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013 - 2020)

Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Oral Proteins and Peptides Market (Drugs, technology, geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast, 2013 - 2020

Oral Proteins and Peptides are the formulations that are orally administered by the patient. Usually, formulations containing proteins and peptides are administered via intravenous and subcutaneous route due to instability ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>